The effect of lipid nanoparticle PEGylation on neuroinflammatory response in mouse brain

Biomaterials

Volumn 34, Issue 32, 2013, Pages 7960-7970

  Huang, Ji yun ^a   Lu, Ying mei ^b   Wang, Huan ^a   Liu, Jun ^c   Liao, Mei hua ^a   Hong, Ling juan ^a   Tao, Rong rong ^a   Ahmed, Muhammad Masood ^a   Liu, Ping ^c   Liu, Shuang shuang ^d   Fukunaga, Kohji ^e   Du, Yong zhong ^c   Han, Feng ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY CITY COLLEGE   (China)

^c ZHEJIANG UNIVERSITY   (China)

^d ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^e TOHOKU UNIVERSITY   (Japan)

Author keywords

Brain; Lipid nanoparticles; Microglia; Neuroinflammatory response; P2X7 receptor; PEGylation

Indexed keywords

LIPID NANOPARTICLES; MICROGLIA; NEUROINFLAMMATORY RESPONSE; P2X7 RECEPTOR; PEGYLATION;

BIOLOGICAL MATERIALS; BRAIN; DRUG DELIVERY; MAMMALS;

NANOPARTICLES;

CALCIUM ION; INTERLEUKIN 1BETA; LIPID; NANOCARRIER; NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN DAMAGE; CELL STRUCTURE; CONFOCAL MICROSCOPY; DRUG DELIVERY SYSTEM; ENZYME ACTIVATION; IN VIVO STUDY; INTRACELLULAR SIGNALING; MICROGLIA; MOLECULAR MECHANICS; MOUSE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PRIORITY JOURNAL;

MUS;

EID: 84881024737     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.07.009     Document Type: Article

References (53)

1. Weiss P.S. Nanotechnology: a molecular four-wheel drive. Nature 2011, 479:187-188.
2. Andrews A.M., Weiss P.S. Nano in the brain: nano-neuroscience. ACS Nano 2012, 6:8463-8464.
3. Weiss P.S. Nanoscience and nanotechnology: present and future. ACS Nano 2010, 4:1771-1772.
4. Lanza G.M., Marsh J.N., Hu G., Scott M.J., Schmieder A.H., Caruthers S.D., et al. Rationale for a nanomedicine approach to thrombolytic therapy. Stroke 2010, 41:S42-S44.
5. Shi N., Zhang Y., Zhu C., Boado R.J., Pardridge W.M. Brain-specific expression of an exogenous gene after i.v. administration. Proc Natl Acad Sci U S A 2001, 98:12754-12759.
6. Cardoso A.L., Costa P., de Almeida L.P., Simões S., Plesnila N., Culmsee C., et al. Tf-lipoplex-mediated c-Jun silencing improves neuronal survival following excitotoxic damage invivo. JControl Release 2010, 142:392-403.
7. Sayes C.M., Gobin A.M., Ausman K.D., Mendez J., West J.L., Colvin V.L. Nano-C60 cytotoxicity is due to lipid peroxidation. Biomaterials 2005, 26:7587-7595.
8. Yu T., Malugin A., Ghandehari H. Impact of silica nanoparticle design on cellular toxicity and hemolytic activity. ACS Nano 2011, 5:5717-5728.
9. Puzyn T., Rasulev B., Gajewicz A., Hu X., Dasari T.P., Michalkova A., et al. Using nano-QSAR to predict the cytotoxicity of metal oxide nanoparticles. Nat Nanotech 2011, 6:175-178.
10. Kaur I.P., Bhandari R., Bhandari S., Kakkar V. Potential of solid lipid nanoparticles in brain targeting. JControl Release 2008, 127:97-109.
11. Trickler W.J., Lantz S.M., Schrand A.M., Robinson B.L., Newport G.D., Schlager J.J., et al. Effects of copper nanoparticles on rat cerebral microvessel endothelial cells. Nanomedicine (Lond) 2012, 7:835-846.
12. 2 nanoparticles. Biomaterials 2010, 31:8043-8050.
13. Gao Y., Gu W., Chen L., Xu Z., Li Y. The role of daidzein-loaded sterically stabilized solid lipid nanoparticles in therapy for cardio-cerebrovascular diseases. Biomaterials 2008, 29:4129-4136.
14. Bondì M.L., Craparo E.F., Giammona G., Drago F. Brain-targeted solid lipid nanoparticles containing riluzole: preparation, characterization and biodistribution. Nanomedicine (Lond) 2010, 5:25-32.
15. Wang J., Rahman M.F., Duhart H.M., Newport G.D., Patterson T.A., Murdock R.C., et al. Expression changes of dopaminergic system-related genes in PC12 cells induced by manganese, silver, or copper nanoparticles. Neurotoxicology 2009, 30:926-933.
16. Wu J., Wang C., Sun J., Xue Y. Neurotoxicity of silica nanoparticles: brain localization and dopaminergic neurons damage pathways. ACS Nano 2011, 5:4476-4489.
17. Dou Y., Wu H.J., Li H.Q., Qin S., Wang Y.E., Li J., et al. Microglial migration mediated by ATP-induced ATP release from lysosomes. Cell Res 2012, 22:1022-1033.
18. Lu Y.M., Tao R.R., Huang J.Y., Li L.T., Liao M.H., Li X.M., et al. P2X7 signaling promotes microsphere embolism-triggered microglia activation by maintaining elevation of Fas ligand. JNeuroinflammation 2012, 9:172.
19. Wang Y., Wang B., Zhu M.T., Li M., Wang H.J., Wang M., et al. Microglial activation, recruitment and phagocytosis as linked phenomena in ferric oxide nanoparticle exposure. Toxicol Lett 2011, 205:26-37.
20. Hu F.Q., Zhang Y.Y., You J., Yuan H., Du Y.Z. pH triggered doxorubicin delivery of PEGylated glycolipid conjugate micelles for tumor targeting therapy. Mol Pharmacol 2012, 9:2469-2478.
21. Yuan H., Chen J., Du Y.Z., Hu F.Q., Zeng S., Zhao H.L. Studies on oral absorption of stearic acid SLN by a novel fluorometric method. Colloids Surf B Biointerfaces 2007, 58:157-164.
22. Stosiek C., Garaschuk O., Holthoff K., Konnerth A. Invivo two-photon calcium imaging of neuronal networks. Proc Natl Acad Sci U S A 2003, 100:7319-7324.
23. Lattarulo C., Thyssen D., Kuchibholta K.V., Hyman B.T., Bacskaiq B.J. Microscopic imaging of intracellular calcium in live cells using lifetime-based ratiometric measurements of Oregon Green BAPTA-1. Methods Mol Biol 2011, 793:377-389.
24. 2+/calmodulin-dependent protein kinase II and its endogenous substrates in the induction of long-term potentiation. JBiol Chem 1995, 270:6119-6124.
25. Tvrdy K., Strano M.S. Nanoimaging: image contrast using time. Nat Nanotech 2011, 7:8-9.
26. Lupien S.J., de Leon M., de Santi S., Convit A., Tarshish C., Nair N.P., et al. Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nat Neurosci 1998, 1:69-73.
27. Müller R.H., Mäder K., Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur J Pharm Biopharm 2000, 50:161-177.
28. Bocca C., Caputo O., Cavalli R., Gabriel L., Miglietta A., Gasco M.R. Phagocytic uptake of fluorescent stealth and non-stealth solid lipid nanoparticles. Int JPharm 1998, 175:185-193.
29. Barandeh F., Nguyen P.L., Kumar R., Iacobucci G.J., Kuznicki M.L., Kosterman A., et al. Organically modified silica nanoparticles are biocompatible and can be targeted to neurons invivo. PLoS One 2012, 7:e29424.
30. Arany Z., Foo S.Y., Ma Y., Ruas J.L., Bommi-Reddy A., Girnun G., et al. HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha. Nature 2008, 451:1008-1012.
31. Dray C., Rougon G., Debarbieux F. Quantitative analysis by invivo imaging of the dynamics of vascular and axonal networks in injured mouse spinal cord. Proc Natl Acad Sci U S A 2009, 106:9459-9464.
32. Harde H., Das M., Jain S. Solid lipid nanoparticles: an oral bioavailability enhancer vehicle. Expert Opin Drug Deliv 2011, 8:1407-1424.
33. Sanders N.N., Peeters L., Lentacker I., Demeester J., De Smedt S.C. Wanted and unwanted properties of surface PEGylated nucleic acid nanoparticles in ocular gene transfer. JControl Release 2007, 122:226-235.
34. Cardona A.E., Pioro E.P., Sasse M.E., Kostenko V., Cardona S.M., Dijkstra I.M., et al. Control of microglial neurotoxicity by the fractalkine receptor. Nat Neurosci 2006, 9:917-924.
35. Pardridge W.M. Blood-brain barrier genomics. Stroke 2007, 38:686-690.
36. Kim G.W., Gasche Y., Grzeschik S., Copin J.C., Maier C.M., Chan P.H. Neurodegeneration in striatum induced by the mitochondrial toxin 3-nitropropionic acid: role of matrix metalloproteinase-9 in early blood-brain barrier disruption?. JNeurosci 2003, 23:8733-8742.
37. 2 delivered to the abdominal cavity. Biomaterials 2010, 31:99-105.
38. Siddiqi N.J., Abdelhalim M.A., El-Ansary A.K., Alhomida A.S., Ong W.Y. Identification of potential biomarkers of gold nanoparticle toxicity in rat brains. JNeuroinflammation 2012, 9:123.
39. AshaRani P.V., Low Kah Mun G., Hande M.P., Valiyaveettil S. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano 2009, 3:279-290.
40. Han F., Tao R.R., Zhang G.S., Lu Y.M., Liu L.L., Chen Y.X., et al. Melatonin ameliorates ischemic-like injury-evoked nitrosative stress: involvement of HtrA2/PED pathways in endothelial cells. JPineal Res 2011, 50:281-291.
41. Zhou H., Chen J., Lu X., Shen C., Zeng J., Chen L., et al. Melatonin protects against rotenone-induced cell injury via inhibition of omi and bax-mediated autophagy in hela cells. JPineal Res 2012, 52:120-127.
42. Glezer I., Simard A.R., Rivest S. Neuroprotective role of the innate immune system by microglia. Neuroscience 2007, 147:867-883.
43. Peng W., Cotrina M.L., Han X., Yu H., Bekar L., Blum L., et al. Systemic administration of an antagonist of the ATP-sensitive receptor P2X7 improves recovery after spinal cord injury. Proc Natl Acad Sci U S A 2009, 106:12489-12493.
44. Monif M., Reid C.A., Powell K.L., Smart M.L., Williams D.A. The P2X7 receptor drives microglial activation and proliferation: a trophic role for P2X7R pore. JNeurosci 2009, 29:3781-3791.
45. Hoffmann A., Kann O., Ohlemeyer C., Hanisch U.K., Kettenmann H. Elevation of basal intracellular calcium as a central element in the activation of brain macrophages (microglia): suppression of receptor-evoked calcium signaling and control of release function. JNeurosci 2003, 23:4410-4419.
46. Avgoustakis K. Pegylated poly(lactide) and poly(lactide-co-glycolide) nanoparticles: preparation, properties and possible applications in drug delivery. Curr Drug Deliv 2004, 1:321-333.
47. Bae J.E., Huh M.I., Ryu B.K., Do J.Y., Jin S.U., Moon M.J., et al. The effect of static magnetic fields on the aggregation and cytotoxicity of magnetic nanoparticles. Biomaterials 2011, 32:9401-9414.
48. 2+ waves trigger responses in microglial cells in brain slices. FASEB J 2002, 16:255-257.
49. Hutter E., Boridy S., Labrecque S., Lalancette-Hébert M., Kriz J., Winnik F.M., et al. Microglial response to gold nanoparticles. ACS Nano 2010, 4:2595-2606.
50. Albanese A., Sykes E.A., Chan W.C. Rough around the edges: the inflammatory response of microglial cells to spiky nanoparticles. ACS Nano 2010, 4:2490-2493.
51. Ryan S.M., Mantovani G., Wang X., Haddleton D.M., Brayden D.J. Advances in PEGylation of important biotech molecules: delivery aspects. Expert Opin Drug Deliv 2008, 5:371-383.
52. Gilmore J.L., Yi X., Quan L., Kabanov A.V. Novel nanomaterials for clinical neuroscience. JNeuroimmune Pharmacol 2008, 3:83-94.
53. Peracchia M.T., Harnisch S., Pinto-Alphandary H., Gulik A., Dedieu J.C., Desmaële D., et al. Visualization of invitro protein-rejecting properties of PEGylated stealth polycyanoacrylate nanoparticles. Biomaterials 1999, 20:1269-1275.